The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: A phase-II study

Breast Cancer Research and Treatment

Volumn 134, Issue 3, 2012, Pages 1169-1178

  Campana, Luca G ^a   Valpione, Sara ^a   Falci, Cristina ^b   Mocellin, Simone ^a   Basso, Michela ^b   Corti, Luigi ^b   Balestrieri, Nicola ^c   Marchet, Alberto ^a   Rossi, Carlo R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c Azienda USLL2 Marca Trevigiana   (Italy)

Author keywords

Advanced cancer chest wall recurrence; Bleomycin; Breast cancer; Electrochemotherapy; Electroporation

Indexed keywords

BLEOMYCIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER GROWTH; CANCER PAIN; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ELECTROCHEMOTHERAPY; FAINTNESS; FEMALE; HAZARD RATIO; HUMAN; LUNG EMBOLISM; MASTECTOMY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; REPEAT PROCEDURE; RESPIRATORY DISTRESS SYNDROME; SKIN METASTASIS; SKIN TOXICITY; SKIN ULCER; SYSTEMIC THERAPY; THORAX WALL CANCER; TREATMENT DURATION; TUMOR VOLUME; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; THORACIC WALL; TREATMENT OUTCOME;

EID: 84868207419     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2095-4     Document Type: Article

References (31)

1. Spratt JS (1967) Locally recurrent cancer after radical mastectomy. Cancer 20:1051-1053
2. Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Cancer 41:1170-1178
3. Bedwinek J (1994) Natural history and management of isolated locoregional recurrence following mastectomy. Semin Radiat Oncol 4:260-269
4. Arriagada R, Le MG, Rochard F, Contesso G (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14:1558
5. Buchanan CL, Dorn PL, Fey J et al (2006) Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg 203:469
6. Van Tienhoven G, Voogd AC, Peterse JL et al (1999) Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 35:32
7. Willner J, Kiricuta IC, Kolbl O (1997) Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 37:853
8. Haylock BJ, Coppin CM, Jackson J et al (2000) Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys 46:355
9. Rauschecker H, Clarke M, Gatzemeier W, Recht (2001) A. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev. (4): CD002195
10. Rols MP (2006) Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. Biochim Biophys Acta 1758(3):423-428
11. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, Savoia P, Bernengo MG (2008) Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 15(8):2215-2222
12. Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, Vecchiato A, Corti L, Rossi CR, Nitti D (2009) Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 16(1):191-199
13. Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, Bond JE, Muir T, Gehl J (2011) Management of cutaneous metastases using electrochemotherapy. Acta Oncol 50(5):621-629
14. Sersa G, Cufer T, Paulin SM, Cemazar M, Snoj M (2011) Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev. doi:10.1016/j.ctrv. 2011.07.006
15. Marty M, Sersa G, Garbay J, Gehl J, Collins C, Snoj M et al (2006) Electrochemotherapy-an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 4:3-13
16. Larkin J, Collins C, Aaron S, Tangney M, Whelan M, O'Reily S et al (2007) Electrochemotherapy-aspects of preclinical development and early clinical experience. Ann Surg 245:469-479
17. Rebersek M, Cufer T, Cemazar M, Kranjc S, Sersa G (2004) Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer. Anticancer Drugs 15:593-597
18. Mir L, Glass L, Sersa G, Teissie J, Domenge C, Miklavcic D et al (1998) Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 77:2336-2342
19. Whelan MC, Larkin JO, Collins CG, Cashman J, Breathnach O, Soden DM et al (2006) Effective treatment of an extensive recurrent breast cancer which was refractory to multimodal therapy with multiple applications of electrochemotherapy. EJC Suppl 4:32-34
20. Therasse P, Arbuck SG, Eisenhauer EA (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
21. Cancer Therapy Evaluation Program (2006) Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003. http://ctep. cancer.gov. Accessed Aug. 9 2006
22. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview o the randomised trials. Lancet 366:2087-2106
23. Campana LG, Valpione S, Mocellin S (2012) Disease control in patients with disseminated superficial melanoma metastases treated with electrochemotherapy. Br J Surg (in press)
24. Aberizk WJ, Silver B, Henderson IC et al (1986) The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer 58:1214
25. Deutsch M, Parsons JA, Mittal BB (1986) Radiation therapy for local-regional recurrent breast carcinoma. Int J Radiat Oncol Biol Phys 12:2061
26. Halverson KJ, Perez CA, Kuske RR et al (1990) Isolated localregional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys 19:851
27. Schwaibold F, Fowble BL, Solin LJ et al (1991) The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 21:299
28. Ballo MT, Strom EA, Prost H et al (1999) Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? Int J Radiat Oncol Biol Phys 44:105
29. Wahl AO, Rademaker A, Kiel KD et al (2008) Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys 70:477
30. Sersa G, Kranjc S, Cemazar M (2000) Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Int J Radiation Oncology Biol Phys 4:1037-1041
31. Kranjc S, Tevz G, Kamensek U, Vidic S, Cemazar M, Sersa G (2009) Radiosensitising effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model. Radiat Res 172:677-685